Pfizer Ventures has led a $102m series A for Capstan Therapeutics while Globis Capital Partners took part in an $85.4m round for Andpad.

Access Industries, Pfizer and SR One were among the investors in a $125m round for Nimbus Therapeutics while Aerwins agreed a reverse takeover.

Alphabet led a $1bn round for its Verily subsidiary while Kimco Realty and The Silverman Group were part of Gotham Greens’ $310m series E.

Hanwha Group took part in a $250m round for Carrot General Insurance while JP Morgan Chase helped lift LetsGetChecked’s series D to $170m.

Reliance Egypt participated in Trukker’s $100m series C round while Merck, Eli Lilly and Heritage Medical all backed Photys’ $75m series A.

SoftBank, Bristol Myers Squibb and Hitachi were among Arsenal Biosciences’ $220m round while MegaChips led a $140m round for Morse Micro.

SHV and DELA took part in an $80m round for Lightyear while Tata Sons provided $40m in funding for Tata 1mg.

Eli Lilly took part in a $50m series A1 round for Neukio Biotherapeutics while Itochu led Docquity’s $44m series C.

SK has provided $50m in funding for Ascend Elements while ServiceNow took part in a $35.6m series C round for Fairmarkit.

Peijia Medical participated in JenaValve’s $100m series C round while L Catterton led Planted Foods’ series B extension, lifting it to $93m.